Apogenix Gmbh Is A Biopharmaceutical Company Located In Heidelberggermanyfounded In 2005 As A Spin Off From The German Cancer Research Centerthe Company Focuses On Developing Innovative Protein Therapeutics Aimed At Treating Cancer And Other Diseases By Manipulating Apoptosis And Utilizing Immunotherapies That Target Tnfsf Dependent Signaling Pathways The Companyae S Lead Drug Candidateasunerceptis Currently In Clinical Development For Solid Tumorshemato Oncological Indicationsand Viral Infectionsincluding Covid 19Apogenix Has Also Developed The Hera Ligand Technology Platformwhich Creates Novel Fusion Proteins With Therapeutic Advantages Over Traditional Biologicsadditionallyapogenix Has Successfully Out Licensed Its Trail Receptor Agonist To Abbviewhich Is Conducting Clinical Studies For Multiple Myeloma With A Strong Focus On Oncology And Infectious Diseasesapogenix Is Committed To Advancing Treatments Through Its Innovative Approaches And Promising Drug Pipeline
